Advertisement
Screener

SPRINGWORKS THERAPEUTICS, INC. Patents: Applications Pending

SPRINGWORKS THERAPEUTICS, INC. Patent Applications Pending

75 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2026-05-07: Application 19670741; Invention MIRDAMETINIB TREATMENT; Applicant SpringWorks Therapeutics Inc.; Status Docketed New Case - Ready for Examination.
  • 2025-10-07: Application 19351393; Invention CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS; Applicant SpringWorks Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
  • 2025-09-03: Application 19317994; Invention TREATMENT OF OVARIAN CANCER WITH NIROGACESTAT; Applicant SpringWorks Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
  • 2025-07-11: Application 19267096; Invention DOSAGE FORMS OF MIRDAMETINIB; Applicant SpringWorks Therapeutics, Inc.; Status Docketed New Case - Ready for Examination.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2026-05-0719670741MIRDAMETINIB TREATMENTSpringWorks Therapeutics Inc.Docketed New Case - Ready for ExaminationUS20260272863A1
Uchenna H. Iloeje
Abraham J. Langseth
Todd Webster Shearer
United States
United States
United States
CENTRAL, DOCKET
2025-10-0719351393CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260034099A1
Kristin Patterson
Mark Hatcher
United States
United States
CENTRAL, DOCKET
2025-09-0319317994TREATMENT OF OVARIAN CANCER WITH NIROGACESTATSpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260000648A1
Shinta CHENG
Todd SHEARER
United States
United States
CENTRAL, DOCKET
2025-07-1119267096DOSAGE FORMS OF MIRDAMETINIBSpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260091006A1
Piero L. RUGGIERO
Kristin PATTERSON
Mark HATCHER
Jiping LIU
Uchenna H. ILOEJE
Abraham J. LANGSETH
United States
United States
United States
United States
United States
United States
CENTRAL, DOCKET
2025-06-13PCTUS2025033474IMPROVED MIRDAMETINIB TREATMENTSPRINGWORKS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
UCHENNA H. ILOEJE
ABRAHAMA J. LANGSETH
United States
United States
2025-06-13PCTUS2025033463IMPROVED MIRDAMETINIB TREATMENTSPRINGWORKS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
UCHENNA H. ILOEJE
ABRAHAMA J. LANGSETH
TODD WEBSTER SHEARER
United States
United States
United States
2025-06-1319237500MIRDAMETINIB TREATMENTSpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250387358A1
Uchenna H. ILOEJE
Abraham J. LANGSETH
United States
United States
BRAUN, MADELINE E
2025-06-1319237417MIRDAMETINIB TREATMENTSpringWorks Therapeutics, Inc.Non Final Action MailedUS20250387356A1
Uchenna H. ILOEJE
Abraham J. LANGSETH
United States
United States
SIMMONS, CHRIS E
2025-06-1119234475DISPERSIBLE FORMULATIONS OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2- FLUORO-4-IODO-PHENYLAMINO)-BENAZMIDE AND USES THEREOFSpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260083690A1
Kristin PATTERSON
Jiping LIU
United States
United States
CENTRAL, DOCKET
2025-03-1819082462TREATMENT OF NEUROFIBROMATOSIS TYPE 1 (NF1) ASSOCIATED PLEXIFORM NEUROFIBROMAS (PN) IN PEDIATRIC PATIENTS WITH MIRDAMETINIBSpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250275932A1
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd Shearer
United States
United States
United States
CENTRAL, DOCKET
2025-02-2419061962SYNTHESIS OF NIROGACESTATSpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250361212A1
Kristin PATTERSON
Mark HATCHER
United States
United States
CENTRAL, DOCKET
2025-02-1419053783NON-LINEAR DOSING OF MIRDAMETINIBSpringWorks Therapeutics Inc.Docketed New Case - Ready for ExaminationUS20250268850A1
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd SHEARER
United States
United States
United States
CENTRAL, DOCKET
2025-02-0563754168IMPROVED MIRDAMETINIB TREATMENTSpringWorks Therapeutics, Inc.Provisional Application Expired
Uchenna H. ILOEJE
Abraham J. LANGSETH
United States
United States
2025-01-2819039603CRYSTALLINE SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODO--PHENYLAMINO)-BENZAMIDE AND USES THEREOFSpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250270166A1
Kristin PATTERSON
Jiping LIU
Ricky Wayne COUCH
Peter Gregory VARLASHKIN
Mai LI
Yonghong GAN
United States
United States
United States
United States
United States
United States
CENTRAL, DOCKET
2025-01-1018993488TREATMENT OF MULTIPLE MYELOMASpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20260027084A1
Todd Webster SHEARER
Rex WILLIAMS
Mark JOHNSON
United States
United States
United States
CENTRAL, DOCKET
2024-10-0718908159TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20250025446A1
Allison LIM
Shinta CHENG
Todd Webster SHEARER
Rex WILLIAMS
Kristin PATTERSON
United States
United States
United States
United States
United States
DAVIS, BRIAN J
2024-08-2718841924FLUORINATED PHENYLAMINO COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSpringworks Therapeutics, Inc.Non Final Action MailedUS20250228812A1
Kristin PATTERSON
Piero L. RUGGIERO
United States
United States
KIM, SEONG JONG
2024-08-2718841882Treatment of cutaneous neurofibromas with MirdametinibSpringWorks Therapeutics, Inc.Non Final Action MailedUS20250170077A1
Uchenna H. Iloeje
Abraham J Langseth
United States
United States
RAMACHANDRAN, UMAMAHESWARI
2024-06-2563663853MIRDAMETINIB TREATMENTSpringWorks Therapeutics, Inc.Provisional Application Expired
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd Webster SHEARER
United States
United States
United States
2024-06-0618736140COMPOSITIONS AND TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics, Inc.Non Final Action MailedUS20240316007A1
Shinta CHENG
Todd Webster SHEARER
Rex WILLIAMS
Kristin PATTERSON
United States
United States
United States
United States
SANCHEZ, JUSTIN CHRISTOPHER
2024-05-16PCTUS2024029649BENZOPIPERAZINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEADSPRINGWORKS THERAPEUTICS, INC.
KATHOLIEKE UNIVERSITEIT LEUVEN
VIB VZW
PCT - International Search Report Mailed to IB
BRIAN LAWHORN
STEPHEN L GWALTNEY
ARNAUD MARCHAND
BART VANDERHOYDONCK
United States
United States
Belgium
Belgium
KIM, HARRY CHONG HYUN
2024-05-16PCTUS2024029643TETRAHYDRONAPTHYRIDINE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEADSPRINGWORKS THERAPEUTICS, INC.
KATHOLIEKE UNIVERSITEIT LEUVEN
VIB VZW
PCT - International Search Report Mailed to IB
BRIAN LAWHORN
ARNAUD MARCHAND
BART VANDERHOYDONCK
STEPHEN L. GWALTNEY
STEPHANE SPIESER
United States
Belgium
Belgium
United States
Belgium
KIM, HARRY CHONG HYUN
2024-05-16PCTUS2024029605BENZIMIDAZOLE AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEADSPRINGWORKS THERAPEUTICS, INC.
KATHOLIEKE UNIVERSITEIT LEUVEN
VIB VZW
PCT - International Search Report Mailed to IB
BRIAN LAWHORN
ARNAUD MARCHAND
BART VANDERHOYDONCK
STEPHEN L. GWALTNEY
United States
Belgium
Belgium
United States
KIM, HARRY CHONG HYUN
2024-04-1218701077COVALENT EGFR INHIBITORS AND METHODS OF USE THEREOFSPRINGWORKS THERAPEUTICS INC
THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
DANA-FARBER CANCER INSTITUTE, INC.
Response to Non-Final Office Action Entered and Forwarded to ExaminerUS20240352021A1
JIANWEI CHE
ZHENGNIAN LI
NATHANAEL S. GRAY
TINGHU ZHANG
STEPHEN LEYCESTER GWALTNEY II
TYLER BEYETT
United States
United States
United States
United States
United States
United States
STOCKTON, LAURA LYNNE
2024-03-2218694483METHODS OF TREATING MULTIPLE MYELOMASpringWorks Therapeutics, Inc.
Seagen Inc.
Non Final Action MailedUS20240343819A1
Phoenix Ho
Heather Alane Van Epps
Mary Campbell
Amy Kim
Shinta Cheng
Todd Shearer
United States
United States
United States
United States
United States
United States
DENT, ALANA HARRIS
2024-03-15PCTUS2024020241DOSAGE FORMS OF MIRDAMETINIBSPRINGWORKS THERAPEUTICS INC.PCT - International Search Report Mailed to IB
PIERO L. RUGGIERO
KRISTIN PATTERSON
MARK HATCHER
JIPING LIU
UCHENNA H ILOEJE
ABRAHAM J LANGSETH
United States
United States
United States
United States
United States
United States
MATOS NEGRON, TAINA DEL MAR
2023-10-3163594671EGFR Covalent Inhibition with MacrocyclesSpringworks Therapeutics Inc.
Dana-Farber Cancer Institute, Inc.
The Board of Trustees of the Leland Stanford Jr. Univ.
Provisional Application Expired
Nathanael S. Gray
Zhengnian Li
Tinghu Zhang
Jianwei Che
Dimitrios Gazgalis
Tyler Beyett
Stephen Leycester Gwaltney II
United States
United States
United States
United States
United States
United States
United States
2023-07-26PCTUS2023028741TREATMENT OF MULTIPLE MYELOMASPRINGWORKS THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
TODD WEBSTER SHEARER
REX WILLIAMS
MARK JOHNSON
United States
United States
United States
MATOS NEGRON, TAINA DEL MAR
2023-07-26PCTUS2023028740DETERMINATION OF BCMA LEVEL ON PLASMA CELLS BY FLOW CYTOMETRYSPRINGWORKS THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
TODD WEBSTER SHEARER
REX WILLIAMS
MARK JOHNSON
United States
United States
United States
MATOS NEGRON, TAINA DEL MAR
2023-05-19PCTUS2023022881TREATMENTS WITH NIROGACESTATSPRINGWORKS THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
ALLISON LIM
SHINTA CHENG
TODD WEBSTER SHEARER
REX WILLIAMS
KRISTIN PATTERSON
United States
United States
United States
United States
United States
THOMAS, SHANE M
2023-03-16PCTUS2023064581TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA WITH MIRDAMETINIBSPRINGWORKS THERAPEUTICS INC.PCT - International Search Report Mailed to IB
BADREDDIN EDRIS
COLLIN TODD
TODD SHEARER
NENAD SARAPA
MARY SMITH
United States
United States
United States
United States
United States
KIM, HARRY CHONG HYUN
2023-03-16PCTUS2023064572TREATMENT OF CUTANEOUS NEUROFIBROMAS WITH MIRDAMETINIBSPRINGWORKS THERAPEUTICS INC.PCT - International Search Report Mailed to IB
UCHENNA H ILOEJE
ABRAHAM J LANGSETH
United States
United States
KIM, HARRY CHONG HYUN
2023-03-16PCTUS2023064569FLUORINATED PHENYLAMINO COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSPRINGWORKS THERAPEUTICS INC.PCT - International Search Report Mailed to IB
KRISTIN PATTERSON
PIERO L RUGGIERO
United States
United States
KIM, HARRY CHONG HYUN
2023-03-16PCTUS2023064562MIRDAMETINIB TREATMENTSPRINGWORKS THERAPEUTICS INC.PCT - International Search Report Mailed to IB
UCHENNA H ILOEJE
ABRAHAM J LANGSETH
TODD SHEARER
United States
United States
United States
KIM, HARRY CHONG HYUN
2023-03-16PCTUS2023064551TREATMENT OF NEUROFIBROMATOSIS TYPE 1 (NF1) ASSOCIATED PLEXIFORM NEUROFIBROMAS (PN) IN PEDIATRIC PATIENTS WITH MIRDAMETINIBSPRINGWORKS THERAPEUTICS INC.PCT - International Search Report Mailed to IB
UCHENNA H ILOEJE
ABRAHAM J LANGSETH
TODD SHEARER
United States
United States
United States
KIM, HARRY CHONG HYUN
2023-03-16PCTUS2023064549NON-LINEAR DOSING OF MIRDAMETINIBSPRINGWORKS THERAPEUTICS INC.PCT - International Search Report Mailed to IB
UCHENNA H ILOEJE
ABRAHAM J LANGSETH
TODD SHEARER
United States
United States
United States
KIM, HARRY CHONG HYUN
2023-03-16PCTUS2023064545TREATMENT OF TUBEROUS SCLEROSIS WITH MIRDAMETINIBSPRINGWORKS THERAPEUTICS INC.PCT - International Search Report Mailed to IB
UCHENNA H ILOEJE
ABRAHAM J LANGSETH
United States
United States
KIM, HARRY CHONG HYUN
2023-03-1663490626DOSAGE FORMS OF MIRDAMETINIBSpringWorks Therapeutics Inc.Provisional Application Expired
Piero L. Ruggiero
Kristin Patterson
Mark Hatcher
Jiping Liu
United States
United States
United States
United States
2023-03-1618185225TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA WITH MIRDAMETINIBSpringWorks Therapeutics Inc.Docketed New Case - Ready for ExaminationUS20230293464A1
Badreddin Edris
Collin Todd
Todd Shearer
Nenad Sarapa
Mary Smith
United States
United States
United States
United States
United States
NOTTINGHAM, KYLE GREGORY
2023-02-01PCTUS2023061762TREATMENT OF OVARIAN CANCER WITH NIROGACESTATSPRINGWORKS THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
SHINTA CHENG
TODD SHEARER
United States
United States
KIM, HARRY CHONG HYUN
2022-11-04PCTUS2022079309COMPOSITIONS AND TREATMENTS WITH NIROGACESTATSPRINGWORKS THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
SHINTA CHENG
TODD WEBSTER SHEARER
REX WILLIAMS
KRISTIN PATTERSON
United States
United States
United States
United States
KIM, HARRY CHONG HYUN
2022-10-1463379617COMBINATION FOR USE IN TREATING CANCERSSPRINGWORKS THERAPEUTICS, INC.Provisional Application Expired
Todd SHEARER
United States
2022-09-1217906089A COMBINATION THERAPY WITH NIROGACESTAT AND A BCMA-DIRECTED THERAPY AND USES THEREOFSpringWorks Therapeutics Inc.Docketed New Case - Ready for ExaminationUS20230121547A1
Todd Webster SHEARER
Badreddin EDRIS
United States
United States
HEITMEIER, KENDALL NICOLE
2022-09-08PCTUS2022076116CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSPRINGWORKS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
KRISTIN PATTERSON
MARK HATCHER
United States
United States
2022-09-01PCTUS2022075839SYNTHESIS OF NIROGACESTATSPRINGWORKS THERAPEUTICS, INC.PCT - International Search Report Mailed to IB
KRISTIN PATTERSON
MARK HATCHER
United States
United States
KIM, HARRY CHONG HYUN
2022-07-2863369733TREATMENT OF MULTIPLE MYELOMASpringWorks Therapeutics Inc.Provisional Application Expired
Todd Webster SHEARER
Rex WILLIAMS
Mark JOHNSON
United States
United States
United States
2022-07-2863369731DETERMINATION OF BCMA LEVEL ON PLASMA CELLS BY FLOW CYTOMETRYSpringWorks Therapeutics Inc.Provisional Application Expired
Todd Webster SHEARER
Rex WILLIAMS
Mark JOHNSON
United States
United States
United States
2022-07-1517758913COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND GAMMA SECRETASE INHIBITORSSpringWorks Therapeutics, Inc.Docketed New Case - Ready for ExaminationUS20230112444A1
Arun BALAKUMARAN
Cesar Adolfo SOMMER
Trevor Michael BENTLEY
Todd Webster SHEARER
Lesley Mary SMITH
United States
United States
United States
United States
United States
WEIDNER, ADAM M
2022-05-2363365193COMPOSITIONS AND TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics Inc.Provisional Application Expired
Shinta CHENG
Todd Webster SHEARER
Rex WILLIAMS
Kristin PATTERSON
United States
United States
United States
United States
2022-05-2063365125COMPOSITIONS AND TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics Inc.Provisional Application Expired
Shinta CHENG
Todd Webster SHEARER
Rex WILLIAMS
Kristin PATTERSON
United States
United States
United States
United States
2022-05-0463364116COVALENT EGFR INHIBITORS AND METHODS OF USE THEREOFSPRINGWORKS THERAPEUTICS INC.
THE BD. OF TRUST. OF THE LELAND STANFORD JR. UNIV.
DANA-FARBER CANCER INSTITUTE, INC.
Provisional Application Expired
JIANWEI CHE
ZHENGNIAN LI
NATHANAEL S. GRAY
TINGHU ZHANG
STEPHEN LEYCESTER GWALTNEY II
TYLER BEYETT
United States
United States
United States
United States
United States
United States
2022-04-0563362490DISCOVERY OF COVALENT EGFR INHIBITOR THROUGH CYSTEINE 775Springworks Therapeutics Inc.
The Bd. of Trust. of the Leland Stanford Jr. Univ.
Dana-Farber Cancer Institute, Inc.
Provisional Application Expired
Nathanael S. Gray
Tinghu Zhang
Zhengnian Li
Jianwei Che
Stephen Leycester Gwaltney II
Dimitrios Gazgalis
United States
United States
United States
United States
United States
United States
2022-03-1763321046TREATMENT OF CUTANEOUS NEUROFIBROMAS WITH MIRDAMETINIBSPRINGWORKS THERAPEUTICS INC.Provisional Application Expired
Uchenna H. ILOEJE
Abraham J. LANGSETH
United States
United States
2022-03-1763321045TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA WITH MIRDAMETINIBSPRINGWORKS THERAPEUTICS INC.Provisional Application Expired
Badreddin EDRIS
Collin TODD
Todd SHEARER
Nenad SARAPA
Mary SMITH
United States
United States
United States
United States
United States
2022-03-1763321043FLUORINATED PHENYLAMINO COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSPRINGWORKS THERAPEUTICS INC.Provisional Application Expired
Kristin PATTERSON
Piero L. RUGGIERO
United States
United States
2022-03-1763321040TREATMENT OF TUBEROUS SCLEROSIS WITH MIRDAMETINIBSPRINGWORKS THERAPEUTICS, INC.Provisional Application Expired
Uchenna H. ILOEJE
Abraham J. LANGSETH
United States
United States
2022-03-1763321036TREATMENT OF TUMORS OR CANCERS WITH MIRDAMETINIBSPRINGWORKS THERAPEUTICS, INC.Provisional Application Expired
Uchenna H. ILOEJE
Abraham J. LANGSETH
Todd SHEARER
United States
United States
United States
2022-02-1763311207COMBINATION THERAPY FOR B-CELL DISORDERSSpringWorks Therapeutics, Inc.
GlaxoSmithKline Intellectual Property Development Limited
Provisional Application Expired
Stephen D. Eastman
Ira Gupta
Beata Holkova
Brandon Kremer
Christopher A. Shelton
Shinta Cheng
Todd Shearer
United States
United States
United States
United States
United States
United States
United States
2022-02-0163267413TREATMENT OF OVARIAN CANCER WITH NIROGACESTATSpringWorks Therapeutics, Inc.Provisional Application Expired
Shinta CHENG
Todd SHEARER
United States
United States
2021-12-0963287947COMBINATIONS OF ANTI-BCMA CAR T CELLS AND GAMMA SECRETASE INHIBITORSSpringWorks Therapeutics, Inc.
Precision BioSciences, Inc.
Provisional Application Expired
Shinta Cheng
Christopher Ryan Heery
Mark Johnson
Todd Shearer
United States
United States
United States
United States
2021-11-0563263635COMPOSITIONS AND TREATMENTS WITH NIROGACESTATSpringWorks Therapeutics Inc.Provisional Application Expired
Shinta CHENG
Todd Webster SHEARER
Rex WILLIAMS
Kristin PATTERSON
United States
United States
United States
United States
2021-10-1463255930COMBINATIONS OF ANTI-BCMA CAR T CELLS AND GAMMA SECRETASE INHIBITORSSpringWorks Therapeutics, Inc.
Precision BioSciences, Inc.
Provisional Application Expired
Shinta Cheng
Christopher Ryan Heery
Mark Johnson
Todd Shearer
United States
United States
United States
United States
2021-09-30PCTUS2021053034NOVEL COMPOUNDSSPRINGWORKS THERAPEUTICS, INC.
VIB VZW
KATHOLIEKE UNIVERSITEIT LEUVEN
RO PROCESSING COMPLETED-PLACED IN STORAGE
ARNAUD MARCHAND
AURELIE CANDI
STEPHEN L. GWALTNEY II.
MATTHIAS VERSELE
BART VANDERHOYDONCK
Belgium
Belgium
United States
Belgium
Belgium
2021-09-2363247637METHODS OF TREATING MULTIPLE MYELOMASpringWorks Therapeutics, Inc.
Seagen Inc.
Provisional Application Expired
Phoenix Ho
Heather Alane Van Epps
Mary Campbell
Amy Kim
Shinta Cheng
Todd Shearer
United States
United States
United States
United States
United States
United States
2021-09-0863241844CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONSSPRINGWORKS THERAPEUTICS, INC.Provisional Application Expired
Kristin PATTERSON
Mark HATCHER
United States
United States
2021-09-0163239696SYNTHESIS OF NIROGACESTATSPRINGWORKS THERAPEUTICS, INC.Provisional Application Expired
Kristin PATTERSON
Mark HATCHER
United States
United States
2021-04-02PCTUS2021025551CO-ADMINISTRATION OF MIRDAMETINIB AND LIFIRAFENIB FOR USE IN TREATING CANCERSSPRINGWORKS THERAPEUTICS, INC.
BEIGENE, LTD.
RO PROCESSING COMPLETED-PLACED IN STORAGE
LUSONG LUO
TODD WEBSTER SHEARER
BADREDDIN EDRIS
ZHIYU TANG
United States
United States
United States
United States
2021-03-12PCTUS2021022177A COMBINATION THERAPY WITH NIROGACESTAT AND A BCMA-DIRECTED THERAPY AND USES THEREOFSPRINGWORKS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
BADREDDIN EDRIS
TODD WEBSTER SHEARER
United States
United States
2021-02-17PCTUS2021018381CRYSTALLINE SOLIDS OF MEK INHIBITOR N-((R)-2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)-BENZAMIDE AND USES THEREOFSPRINGWORKS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
KRISTIN PATTERSON
JIPING LIU
YONGHONG GAN
PETER GREGORY VARLASHKIN
MAI LI
RICKY WAYNE COUCH
United States
United States
United States
United States
United States
United States
2021-02-17PCTUS2021018373DISPERSIBLE FORMULATIONS OF N-((R)-2,3-DIHYDROXYPROPOXY)-3,4- DIFLUORO-2-(2-FLUORO-4-IODO-PHENYLAMINO)-BENZAMIDE AND USES THEREOFSPRINGWORKS THERAPEUTICS, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
JIPING LIU
KRISTIN PATTERSON
United States
United States
2021-01-15PCTUS2021013705COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND GAMMA SECRETASE INHIBITORSSPRINGWORKS THERAPEUTICS, INC.
ALLOGENE THERAPEUTICS, INC.
RO PROCESSING COMPLETED-PLACED IN STORAGE
TREVOR MICHEAL BENTLEY
TODD WEBSTER SHEARER
LESLEY MARY SMITH
ARUN BALAKUMARAN
CESAR ADOLFO SOMMER
United States
United States
United States
United States
United States
2020-11-2363117281COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND GAMMA SECRETASE INHIBITORSSpringWorks Therapeutics, Inc.
Allogene Therapeutics, Inc.
Provisional Application Expired
Arun BALAKUMARAN
Cesar Adolfo SOMMER
Trevor Michael BENTLEY
Todd Webster SHEARER
Lesley Mary SMITH
United States
United States
United States
United States
United States
2020-04-0363005153Co-Administration of Mirdametinib and Lifirafenib for Use in Treating CancersSpringWorks Therapeutics, Inc.
BeiGene, Ltd.
Provisional Application Expired
Badreddin Edris
Lusong Luo
Todd Webster Shearer
Zhiyu Tang
United States
United States
United States
United States
2020-03-1362989372COMBINATION THERAPY WITH NIROGACESTAT AND A BCMA-DIRECTED THERAPY AND USES THEREOFSPRINGWORKS THERAPEUTICS, INC.Provisional Application Expired
Todd Webster Shearer
Badreddin Edris
United States
United States
2020-01-1662962014COMBINATION THERAPIES OF CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND GAMMA SECRETASE INHIBITORSSpringWorks Therapeutics, Inc.
Allogene Therapeutics, Inc.
Provisional Application Expired
Arun Balakumaran
Cesar Adolfo Sommer
Trevor Michael Bentley
Todd Webster Shearer
Lesley Mary Smith
United States
United States
United States
United States
United States